Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ventricular Tachycardia Ablation or Escalated aNtiarrhythmic Drugs in ISchemic Heart Disease

NCT00905853 is registered in ClinicalTrials.gov with John Sapp as lead sponsor.

NCT NCT00905853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00905853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ventricular Tachycardia Ablation or Escalated aNtiarrhythmic Drugs in ISchemic Heart Disease
Lead sponsor
John Sapp
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2009
Completion date
December 31, 2015
Enrollment
260 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent ventricular tachycardia